Irritable bowel syndrome with constipation [DS:H01615]
Comment
CAS Registry number (136790-76-6) are given for the tautomeric monocyclic isomer
Prostaglandin E1 derivative
Treatment of constipation and bowel preparation
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A06 DRUGS FOR CONSTIPATION
A06A DRUGS FOR CONSTIPATION
A06AX Other drugs for constipation
A06AX03 Lubiprostone
D04790 Lubiprostone (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Anti-Constipation Agents
Lubiprostone
D04790 Lubiprostone (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
235 Purgatives, clysters
2359 Others
D04790 Lubiprostone (JAN/USAN/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01770 Laxative
D04790 Lubiprostone
Drug classes [BR:br08332]
Gastrointestinal agent
DG01770 Laxative
D04790 Lubiprostone
Target-based classification of drugs [BR:br08310]
Ion channels
Other ion channels
Chloride channel
CLCN2
D04790 Lubiprostone (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04790
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04790
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04790